DRC Bundibugyo Ebola Outbreak
Analysis based on 9 articles · First reported May 16, 2026 · Last updated May 16, 2026
The new Ebola outbreak of the Bundibugyo strain in the Democratic Republic of the Congo, with its high lethality and lack of vaccine, could negatively impact the healthcare and pharmaceutical industries due to increased demand for research and development of treatments. The cross-border spread to Uganda also raises concerns about regional stability and economic activity.
A new Ebola outbreak of the Bundibugyo strain has emerged in the Democratic Republic of the Congo, with its health minister, Roger Kamba, warning of a very high lethality rate (up to 50%) and no available vaccine or specific treatment. The death toll has reached 80, with 246 suspected cases. The outbreak has also claimed one life in neighboring Uganda, a national of the Democratic Republic of the Congo, raising concerns about cross-border transmission. The World Health Organization and United States — Centers for Disease Control and Prevention are involved in the response, with the World Health Organization preparing to airlift medical supplies. This is the 17th Ebola outbreak in the Democratic Republic of the Congo, with previous outbreaks causing significant fatalities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard